Company news

LivaNova PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

LivaNova Appoints Susan Podlogar as a New Director

October 7, 2024

LivaNova to Announce Third-Quarter 2024 Results

September 24, 2024

LivaNova to Present at the Baird Global Healthcare Conference

August 18, 2024

LivaNova Reports Second-Quarter 2024 Results

July 30, 2024

LivaNova to Announce Second-Quarter 2024 Results

June 17, 2024

LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients

June 5, 2024

LivaNova to Present at the Goldman Sachs Healthcare Conference

May 22, 2024

LivaNova Reports First-Quarter 2024 Results

April 30, 2024

LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer

April 29, 2024

LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident

April 24, 2024

LivaNova to Announce First-Quarter 2024 Results

March 20, 2024

LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea

March 19, 2024

LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029

March 4, 2024

LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes

March 3, 2024

LivaNova Reports Fourth-Quarter and Full-Year 2023 Results

February 20, 2024

LivaNova Announces Vladimir A. Makatsaria as CEO and Board Director

February 4, 2024

LivaNova to Wind Down Advanced Circulatory Support Business Unit

January 7, 2024

LivaNova to Announce Fourth-Quarter and Full-Year 2023 Results

January 3, 2024

LivaNova to Present at the Piper Sandler Healthcare Conference

November 8, 2023

LivaNova Reports Third-Quarter 2023 Results

October 31, 2023

LivaNova to Present at the Stifel and Wolfe Healthcare Conferences

October 24, 2023

LivaNova Board Appoints J. Christopher Barry as New Director

October 5, 2023

LivaNova Announces Marco Dolci, President of Cardiopulmonary, to Retire at the End of 2023

September 20, 2023

LivaNova to Announce Third-Quarter 2023 Results

September 19, 2023

LivaNova Unveils Essenz In-Line Blood Monitor with U.S. FDA 510(k) Clearance and CE Mark

August 29, 2023

LivaNova Reports Second-Quarter 2023 Results

July 25, 2023

LivaNova to Announce Second-Quarter 2023 Results

June 13, 2023

LivaNova Announces 150th Bipolar Depression Patient Randomized in RECOVER Clinical Study

June 12, 2023

LivaNova Reports First-Quarter 2023 Results

May 2, 2023

LivaNova Board of Directors Announce Leadership Changes

April 13, 2023

LivaNova to Announce First-Quarter 2023 Results

March 21, 2023

LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures

March 8, 2023

LivaNova Reports Fourth-Quarter and Full-Year 2022 Results

February 21, 2023

LivaNova Initiates Limited Commercial Release in Europe of the Essenz Perfusion System for Cardiopulmonary Bypass Procedures

February 7, 2023

LivaNova Launches SenTiva DUO

February 1, 2023

LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results

January 17, 2023

LivaNova Announces Receipt of Close-Out of Warning Letter from U.S. Food and Drug Administration

December 12, 2022

LivaNova to Present Scientific Data at American Epilepsy Society 2022 Annual Meeting

November 29, 2022

LivaNova Receives 510(k) Clearance for ECMO from FDA for LifeSPARC, the Next-generation Advanced Circulatory Support System

November 16, 2022

LivaNova to Present at the Stifel, Wolfe and Piper Sandler Healthcare Conferences

November 7, 2022

LivaNova Reports Third-Quarter 2022 Results

November 1, 2022

LivaNova to Announce Third-Quarter 2022 Results

September 20, 2022

LivaNova Board Appoints Brooke Story as a New Director

September 14, 2022

LivaNova Reports Second-Quarter 2022 Results

August 2, 2022

LivaNova to Announce Second-Quarter 2022 Results

June 21, 2022

LivaNova Elects Peter Wilver to Board of Directors

June 13, 2022

LivaNova to Present at the Goldman Sachs Global Healthcare Conference

May 24, 2022

LivaNova Reports First-Quarter 2022 Results

May 3, 2022

LivaNova Initiates Targeted Commercial Launch of the Essenz Patient Monitor for Cardiopulmonary Bypass Procedures

April 7, 2022

LivaNova to Announce First-Quarter 2022 Results

March 23, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks

The 5 newest of 38 decks. Every deck is listed under its year.